Study S001249

Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05829460
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: WITHDRAWN
Enrollment: 0
Start: 2025-03-12
Primary completion: 2030-04-30
Lead sponsor: Washington University School of Medicine
Conditions: Endometrial Hyperplasia
Interventions: DRUG:Semaglutide; DRUG:Placebo; DRUG:LNG-IUD (Progestin); BEHAVIORAL:Telemedicine behavioral weight program
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Number of patients with endometrial hyperplasia free biopsy with uterine preservation [At 2 years (or exit from study)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.